Evidence map›Paper›PMID 26650177›Full record

ArticleInternational journal of cancer2016

Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.

Song Yao, Stephen A Haddad, Qiang Hu, Song Liu, Kathryn L Lunetta, Edward A Ruiz-Narvaez, Chi-Chen Hong, Qianqian Zhu, Lara Sucheston-Campbell, Ting-Yuan David Cheng and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. The African-Specific Variant in the Duffy Antigen Receptor for Chemokines Gene, CD8+ T-Cell Density, and Aggressive Breast Cancer Subtypes in Black Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Observational
  6. Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018
    Review
  7. Genetic polymorphism of calcium-sensing receptor in women with breast cancer.Medical oncology (Northwood, London, England) · 2018
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Song YaoDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
Stephen A HaddadSlone Epidemiology Center at Boston University, Boston, MA.
Qiang HuDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY.
Song LiuDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY.
Kathryn L LunettaDepartment of Biostatistics, Boston University School of Public Health, Boston, MA.
Edward A Ruiz-NarvaezSlone Epidemiology Center at Boston University, Boston, MA.
Chi-Chen HongDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
Qianqian ZhuDepartment of Biostatistics and Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY.
Lara Sucheston-CampbellDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
Ting-Yuan David ChengDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
Jeannette T BensenDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Candace S JohnsonDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY.
Donald L TrumpInova Schar Cancer Institute, Falls Church, VA.
Christopher A HaimanDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA.
Andrew F OlshanDepartment of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Julie R PalmerSlone Epidemiology Center at Boston University, Boston, MA.
Christine B AmbrosoneDepartment of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY.
Roswell Park Comprehensive Cancer Center · USBoston University · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
FOLLOW-UP STUDY FOR CAUSES OF ILLNESS IN BLACK WOMENR01CA058420 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 1999 to 2013
$20.7M
Reproduction, Lactation and Hormonal Factors in Breast Cancer SubtypesP01CA151135 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B., OLSHAN, ANDREW · 2011 to 2017
$18.1M
A Follow-up Study for Causes of Cancer in Black WomenUM1CA164974 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENBERG, LYNN · 2012 to 2017
$13.7M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Gene Polymorphisms in Relation to Cancer in Black WomenR01CA098663 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PALMER, JULIE R · 2003 to 2012
$5.3M
Race &Risk Factors for Early/Aggressive Breast CancerR01CA100598 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI AMBROSONE, CHRISTINE B. · 2004 to 2008
$4.8M
Uncoupling obesity from breast cancer in African American womenU01CA182898 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DENIS, GERALD V, PALMER, JULIE R · 2013 to 2017
$3.1M
mTOR pathway in breast cancer subtypes by race: A molecular pathological studyK07CA201334 · NCI · UNIVERSITY OF FLORIDA · PI CHENG, TING-YUAN · 2016 to 2020
$693k
NCI NIH HHS K07 CA201334NCI NIH HHS P01 CA151135NCI NIH HHS P01CA151135NCI NIH HHS P30 CA016056NCI NIH HHS P50 CA058223NCI NIH HHS R01 CA058420NCI NIH HHS R01CA058420NCI NIH HHS R01 CA098663NCI NIH HHS R01CA098663NCI NIH HHS R01 CA100598NCI NIH HHS R01CA100598NCI NIH HHS U01 CA182898NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA1480655NCI NIH HHS UM1 CA164974NCI NIH HHS UM1CA164974NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Studies of genetic variations in vitamin D-related pathways and breast cancer risk have been conducted mostly in populations of European ancestry, and only sparsely in African Americans (AA), who are known for a high prevalence of vitamin D deficiency. We analyzed 24,445 germline variants in 63 genes from vitamin D-related pathways in the African American Breast Cancer Epidemiology and Risk (AMBER) consortium, including 3,663 breast cancer cases and 4,687 controls. Odds ratios (OR) were derived from logistic regression models for overall breast cancer, by estrogen receptor (ER) status (1,983 ER positive and 1,098 ER negative), and for case-only analyses of ER status. None of the three vitamin D-related pathways were associated with breast cancer risk overall or by ER status. Gene-level analyses identified associations with risk for several genes at a nominal p ≤ 0.05, particularly for ER- breast cancer, including rs4647707 in DDB2. In case-only analyses, vitamin D metabolism and signaling pathways were associated with ER- cancer (pathway-level p = 0.02), driven by a single gene CASR (gene-level p = 0.001). The top SNP in CASR was rs112594756 (p = 7 × 10(-5), gene-wide corrected p = 0.01), followed by a second signal from a nearby SNP rs6799828 (p = 1 × 10(-4), corrected p = 0.03). In summary, several variants in vitamin D pathways were associated with breast cancer risk in AA women. In addition, CASR may be related to tumor ER status, supporting a role of vitamin D or calcium in modifying breast cancer phenotypes.

Indexed as

AdolescentAdultAgedBiomarkers, TumorBlack or African AmericanBreast NeoplasmsFemaleGenetic Predisposition to DiseaseGenetic VariationGenotypeHumansMiddle AgedOdds RatioPolymorphism, Single NucleotideReceptors, Calcium-SensingReceptors, EstrogenBiomarkers, TumorCASR protein, humanReceptors, Calcium-SensingReceptors, EstrogenVitamin DAfrican Americanbreast cancerestrogen receptorgenetic variationvitamin D

Identifiers

PMID26650177
PMCPMC5087916
OpenAlexW2191279231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.